Emerade 150, 300 and 500 microgram adrenaline auto-injector devices. Further update 29th November
Further to the alert yesterday of a pharmacy level recall on Emerade all strengths, all Emerade devices will now be unavailable for the foreseeable future. A management plan has been developed in collaboration with NHS England and NHS Improvement (NHSE&I), the British Society for Allergy & Clinical Immunology (BSACI), the MHRA and National patient groups....
Recent Comments